Evidence map›Paper›PMID 33909254›Full record

ArticleCardiovascular toxicology2021

Ellagic Acid Prevents Ca

Bilge E Yamasan, Tanju Mercan, Orhan Erkan, Semir Ozdemir

Abstract read
PubMed Publisher
In one paragraph

Article in Cardiovascular toxicology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Bilge E YamasanDepartment of Biophysics, Akdeniz University Faculty of Medicine, Antalya, Turkey.
Tanju MercanDepartment of Biophysics, Akdeniz University Faculty of Medicine, Antalya, Turkey.
Orhan ErkanDepartment of Biophysics, Akdeniz University Faculty of Medicine, Antalya, Turkey.
Semir OzdemirDepartment of Biophysics, Akdeniz University Faculty of Medicine, Antalya, Turkey. osemir@akdeniz.edu.tr.ORCID http://orcid.org/0000-0002-4807-7344
Akdeniz University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to investigate whether ellagic acid (EA) treatment can prevent changes in contractile function and Ca

Indexed as

AnimalsAntioxidantsCalciumCalcium-Binding ProteinsCalcium-Calmodulin-Dependent Protein Kinase Type 2Calcium Channels, L-TypeCalcium SignalingCardiomegalyCells, CulturedEllagic AcidMaleMyocardial ContractionMyocytes, CardiacNADPH OxidasesOxidative StressPhospholambanAntioxidantsCalciumCalcium-Binding ProteinsCalcium-Calmodulin-Dependent Protein Kinase Type 2Calcium Channels, L-TypeCyba protein, ratEllagic AcidNADPH Oxidasesneutrophil cytosolic factor 1PhospholambanEllagic acidIntracellular Ca2+Myocyte shorteningPathological cardiac hypertrophyReactive oxygen species

Identifiers

PMID33909254
OpenAlexW3159154215

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.